Abbott secures US FDA approval for a new MitraClip device

23/04/2019
4-1-(1).jpg

          Abbott has gained approval from the US Food and Drug Administration (FDA) to use its third generation MitraClip heart valve repair device for treatment of leaky mitral valves. Transcatheter clip-based therapy eliminates the need for invasive heart surgery. This next-generation device has advanced steering, navigation and positioning features which allow easy usage in difficult anatomies. The new system also facilitates more accurate placement, utilizing a second clip size with longer arms to expand its reach to enhance treatment of patients with more complex anatomies.
 

Page view : 21